Los Angeles Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-6,205
| Closed | -$224K | – | 1222 |
|
2024
Q4 | $224K | Hold |
6,205
| – | – | ﹤0.01% | 1026 |
|
2024
Q3 | $263K | Buy |
+6,205
| New | +$263K | ﹤0.01% | 1055 |
|
2022
Q2 | – | Sell |
-2,092
| Closed | -$243K | – | 1460 |
|
2022
Q1 | $243K | Buy |
2,092
+112
| +6% | +$13K | ﹤0.01% | 1314 |
|
2021
Q4 | $298K | Sell |
1,980
-174
| -8% | -$26.2K | ﹤0.01% | 1240 |
|
2021
Q3 | $257K | Hold |
2,154
| – | – | ﹤0.01% | 1355 |
|
2021
Q2 | $210K | Sell |
2,154
-138
| -6% | -$13.5K | ﹤0.01% | 1486 |
|
2021
Q1 | $202K | Sell |
2,292
-315
| -12% | -$27.8K | ﹤0.01% | 1540 |
|
2020
Q4 | $249K | Sell |
2,607
-775
| -23% | -$74K | ﹤0.01% | 1427 |
|
2020
Q3 | $384K | Sell |
3,382
-3,210
| -49% | -$364K | ﹤0.01% | 1190 |
|
2020
Q2 | $652K | Sell |
6,592
-21,293
| -76% | -$2.11M | ﹤0.01% | 1010 |
|
2020
Q1 | $1.79M | Buy |
27,885
+15,055
| +117% | +$969K | 0.01% | 562 |
|
2019
Q4 | $765K | Buy |
12,830
+1,270
| +11% | +$75.7K | ﹤0.01% | 907 |
|
2019
Q3 | $682K | Buy |
11,560
+7,860
| +212% | +$464K | ﹤0.01% | 907 |
|
2019
Q2 | $239K | Sell |
3,700
-3,370
| -48% | -$218K | ﹤0.01% | 1250 |
|
2019
Q1 | $449K | Buy |
+7,070
| New | +$449K | ﹤0.01% | 1114 |
|
2017
Q2 | – | Sell |
-1,325
| Closed | -$16K | – | 1249 |
|
2017
Q1 | $16K | Buy |
+1,325
| New | +$16K | ﹤0.01% | 1133 |
|